Severe bleeding associated with worsening thrombocytopenia following alpha interferon therapy for autoimmune thrombocytopenic purpura.
Benjamin
S
S
Department of Haematology, St. Mary's Hospital Medical School, London.
Bain
B J
BJ
Dodsworth
H
H
D003131:Combined Modality Therapy; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D010976:Platelet Count / Q000187:drug effects; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications / Q000628:therapy*; D011994:Recombinant Proteins; D012769:Shock / Q000209:etiology; D013921:Thrombocytopenia / Q000139:chemically induced*
D007155:Immunologic Factors; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins